Atogepant (QULIPTA) was just approved by the FDA as a daily oral preventive treatment for migraine. On this episode of Heads UP, Dr. Lindsay Weitzel asks migraine clinical trial expert Dr. Tim Smith all the hard questions: Can we take gepants like Nurtec or Ubrelvy…
The U.S. Food and Drug Administration (FDA) approved QULIPTA™ (atogepant) for the preventive treatment of episodic migraine in adults. QULIPTA is the first and only oral calcitonin gene-related peptide (CGRP) receptor antagonist (gepant) specifically developed for the preventive treatment of migraine disease. The approval is…
Dr. Lindsay Weitzel talks to Dr. Tim Smith about the specifics of Trudhesa, the first DHE nasal spray to utilize Precision Olfactory Delivery (POD) technology. Trudhesa was just approved by the FDA. When will it be available to us? How soon do we have to…
Have you tried telemedicine for your headache and migraine care? What are the benefits and limitations? How do you know when you actually need to be seen in person? This week on Heads Up Dr. Lindsay Weitzel talks to Dr. Brad Torphy, Medical Director of…
I find this to be the most interesting time of year for me to be writing this particular article. This is because of the spring flowers blooming outside right now. The flowers have special meaning to me when it comes to discussing long-awaited migraine medications….
Supplement information related to migraine can be very confusing. Which vitamin supplements should we take? Why should we take them? How long before we should expect to feel an effect? It’s so easy for us to think – if all these medicines aren’t helping why…
Question: I dread the springtime because my migraine attacks get more frequent and much worse in intensity. What do you recommend? Is there something I can do to lessen the severity? Thanks, Susan Answer: Unfortunately allergic rhinitis and asthma are very common comorbidities of migraine. One study…
Cannabis is used by many people with migraine and other headache disorders to help control their symptoms. In the last few years, some studies have shown it to be effective for some people. Recent data has emerged showing that it may have a rebound effect…
Last week the National Headache Foundation team and many of the advocates from the migraine and headache community took part in an important annual advocacy event called Headache on the Hill. If you were not able to participate, there is still an opportunity for you…
Subscribe to our Monthly e-Newsletter
Gain access to the most current migraine and headache information, prevention,
treatment, research, and news.
